Agomab Therapeutics AGMB Income Statement (2024-2025)

NASDAQ AGMB
$13.43 -0.32 (-2.33%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Dec2024 Dec2025
Additional items
Shares Outstanding (Quarter) 541,126.00541,126.00
Shares Outstanding (Diluted) (Quarter) 541,126.00541,126.00
Shares Outstanding (Entity) (Quarter) 541,126.00541,126.00
Revenue & Cost
Interest expenses
Interest Expenses (Quarter) -381488.56-154817.79